Fulgent Genetics - FLGT Company Future Sales Volume

Fulgent Genetics, Inc. (FLGT) - corporate logo

In-house sequencing capacities and IT solutions create a defensive barrier for Fulgent Genetics, Inc. (FLGT) in oncology diagnostics. However, the decline in post-pandemic demand and pricing pressure from insurance companies create risks. The firm's future sales projections confirm these trends, where the value of 0.33 corresponds to the current metric. Meanwhile, the digitalization of reports and laboratory energy efficiency help the company comply with ESG environmental standards.

Company Projected Revenue: Fulgent (FLGT) for 07/04/2022 - 11/16/2026

Summary analytical data breakdowns for Fulgent (FLGT)

Summary company analytics:Fulgent Genetics, Inc. FLGT
Brand item of Fulgent Corp

This indicator assesses revenue generation potential by determining the operational resilience of the business and its suitability for long-term investment through an analysis of cash flow stability. The trend in planned sales revenue reflects the scaling efficiency of Fulgent Genetics, Inc. (FLGT) high-throughput laboratories, where the integration of IT platforms for bioinformaticians directly converts into growth in genetic testing volumes and commercial expansion.

Key competitors

Company Projected Revenue Agilent (A)|Projected Sales Volume Quest Diagnostics Incorporated (DGX)|Company Projected Revenue Illumina Corp ILMN|EXAS: Company Revenue Forecast|RVTY: Company Future Sales Volume|Company Sales Forecast bio-rad.com (BIO)|NNNN: Projected Sales Volume|Sotera Health - Company Future Revenue|QDEL (quidel.com) - Projected Sales Volume|OPK: Company Future Revenue|Company Future Sales Volume CDNA (CareDx)|Projected Sales Volume Maravai LifeSciences (MRVI)|Projected Sales Volume LAB (Fluidigm)|Cytek Biosciences - Company Projected Revenue|OSUR: Company Future Sales Volume|XGN (exagen.com) - Company Revenue Forecast|MDXH: Projected Sales Volume|Lucid Diagnostics Inc. (LUCD) - Projected Sales Volume|PRE (Prenetics Global) - Projected Sales Volume|Company Expected Sales Volume imdxinc.com IMDX|Company Projected Revenue Trinity Biotech plc (TRIB)|Projected Sales Volume ProPhase (PRPH)|Projected Sales Volume AIMD (ainos.com)|Company Future Sales Co-Diagnostics, Inc. (CODX)|heartsciences.com - Projected Sales Volume|Biomerica, Inc (BMRA) - Company Future Sales Volume|Cardio Diagnostics (CDIO) - Company Projected Revenue|ONCO - Company Future Sales|VRAX (Virax Biolabs Corp) - Projected Sales Volume|Bluejay Diagnostics, Inc. (BJDX) - Company Future Sales|Projected Sales Volume AWH|Accelerate Diagnostics Inc. - Company Revenue Forecast|Centogene - Company Future Sales Volume|Enzo Biochem, Inc. (ENZ) - Company Expected Sales Volume|Company Projected Revenue Volume Fresh2 Group Limited FRES|Company Future Sales gtglabs.com GENE|23andMe Holding Co (ME) - Company Projected Revenue|Company Revenue Forecast PMD